The dried powdered leaves of Globimetula braunii (Engler) Van Tiegh were effectively extracted by the cold extraction method. Purification of the EtOAcsoluble and MeOH-soluble extracts successfully yielded two lactones namely (R)-6-[(S)-2-hydroxy-4-(4-hydroxyphenyl)butyl]-5,6-dihydropyran-2-one (dodoneine) 1 and (1R,5S,7S)-[2-(4-hydroxyphenyl)ethyl]-2,6-dioxabicyclo[3.3.1]-nonan-3-one (2), together with five flavonoids namely quercetin 3, (+)-catechin 4, quercitrin 5, rutin 6 and avicularin 7. Their structures were established by spectroscopic means, and the absolute configuration of compound 1 was confirmed by X-ray analysis.
Africa is endowed with rich biodiversity resources that are projected to contain up to 45,000 species of plants, out of which 5,000 species are used medicinally. The continent has a long antiquity of the use of plants and up to 80 % of the people in some Africa countries rely on orthodox medicinal plants as a source of medications [1] [2] . This results from the belief that medicinal plants are more accessible, economically affordable, and more acceptable to the body, with lesser side effects than synthetic drugs [3] . There is still a dearth of updated, inclusive compilations of promising medicinal plants from the African continent. This is coupled with the unregulated devastation of the vegetation of tropical rain forest, which poses a risk to medicinal plants. There is, therefore, every need to deepen research into African medicinal flora, especially those asserted to have positive effects in severe disorders such as epilepsy. One of the African medicinal plants with scant or no scientific reports on phytochemical investigations targeted at isolating bioactive compounds is Globimetula braunii.
Globimetula braunii (Engler) Van Tiegh is a member of the Loranthaceae family that is represented by 75 genera and 1000 species, generally called mistletoe. It is a bushy parasitic plant found in a variety of host plants with woody stems from Ghana to Nigeria and widely dispersed across central tropical Africa. The leaves are simple, stringy and evergreen. Timbered suckers often regarded as adventitious roots connect to and infiltrate the branches of the host tree or shrub by a structure called the haustorium, through which they absorb water and nutrients from the host tree [4] . The leaves have gained relevance as being useful in folklore medicine for the management of rheumatism, headache, pains, and pulmonary problems. They are also effective against diabetes, diarrhea, hypertension, and epilepsy [4] [5] [6] . Previous studies on the anticonvulsant activity of the ethyl acetate fraction of this plant suggested that this fraction may contain psychoactive compounds and require further phytochemical investigation [7] . Thus, this study was conducted to isolate compounds from the leaves of Globimetula braunii and here we wish to report for the first time the chemical constituents of this species.
The powdered leaves of G. braunii were sequentially extracted with n-hexane, CH 2 Cl 2 , and MeOH at room temperature. The MeOH crude extract was further suspended in water before partitioned with n-hexane, CHCl 3 , EtOAc, and MeOH to yield the n-hexane-soluble, CHCl 3 -soluble, EtOAc-soluble and MeOH-soluble extracts. Chromatographic separations using vacuum liquid chromatography (VLC) and column chromatography (CC) on silica gel of the EtOAc-soluble extract, followed by recrystallization afforded compounds 1, 2, 3 and 4. Purification by VLC and CC followed by preparative thin layer chromatography (PTLC) of the MeOHsoluble extract furnished compounds 5, 6, and 7. Compounds 1-7 ( Figure 1 ) were characterized by comparison of their spectroscopic data with respective literature reports [8] [9] [10] [11] [12] [13] [14] [15] .
The first proposed structure of 1 was published in 2007 by Ouedraogo et al. [8] . The authors outlined the isolation and structure determination of 1 using standard spectroscopic data, sophisticated synthetic transformations and the X-ray crystallographic structure of the camphor sulfonate derivative 1a to determine the absolute configuration ( Figure 2 ) [8] . However, until now, no X-ray crystal structure of 1 has been published. The asymmetric unit of 1 features one complete unit of 1 accompanied by one solvent water molecule. This is noteworthy, as Ouedraogo et al. state that the original isolation involved the slow crystallization of an oil with one molecule of water. The overall constitution could be reliably determined as the expected (R)-6-[(S)-2-hydroxy-4-(4-hydroxyphenyl)butyl]-5,6-dihydropyran-2-one ( Figure 3 ). As previously reported by Ouedraogo et al. the configurations of C6 and C2' are R and S, respectively, which, compared to the structure of 1a, is indeed a preserved configuration [8] . The dihydropyran-2-one ring has the half-chair conformation. This feature is shared with other literature examples containing a dihydropyran-2-one moiety such as 8-15 ( Figure 4 ) [16] [17] [18] [19] [20] [21] [22] . The deviations of the six-membered ring O1-C6 from its least-squares plane are quite characteristic of these compounds. The mean sixmembered ring displacement of compound 1 is 0.187 Å with the C6 atom furthest away from the mean-plane at 0.314 Å. This is similar to the previously reported compounds 8-15 which have a mean sixmembered ring displacement of 0.178-0.179 Å and an average C6 displacement from the mean-plane at 0.301-0.325 Å [16] [17] [18] [19] [20] [21] [22] . The rotation angle of the hydroxyphenyl moiety and dihydropyran-2-one moiety around the butyl chain of compound 1 is 129.87(6)° which, compared to compounds 8-15, falls close to the range for these types of compounds at 14.20-120.25° suggesting that high degree of rotations are possible [16] [17] [18] [19] [20] [21] [22] . As with many natural products implicated as potential therapeutics, the presence of hydrogen bond donors and acceptors is generally accepted as a key feature. Compound 1 features two distinct hydrogen bonding networks that are key in the molecular packing of the crystal structure. The first of these is between the phenyl hydroxy moiety (O4), the butyl hydroxy moiety (O3) and solvent water molecules (O5). As seen in Figure 4 ). Of the aforementioned examples (8-15), these two hydrogen bonding networks are unique in their packing [16] [17] [18] [19] [20] [21] [22] . The head-to-tail overlap also removes the possibility of -stacking within the structure inhibiting the formation of -aggregates. To the best of our knowledge, this is the first report on the isolation and structural elucidation of (R) [8] and Pragmenthera capitata [9] . Compound 2 is isolated as colorless crystals with m.p. 171-172 o C and α
NPC Natural Product Communications
-
Lactones and flavonoids from the leaves of Globimetula braunii
Natural Product Communications Vol. 12 (9) [8] ). Compound 2 has been isolated from P. capitata [9] , Globimetula dinklagei [10] , Tapinanthus bangwensis [23] , while 3 was isolated from P. capitata [9] Scurrula parasitica [24] , and Taxillus theifer [25] . The occurrence of 4 was also reported in S. parasitica [24] , T. theifer [25] , Laranthus koi [12] and S. atropurpurea [26] . Compound 5 was previously isolated from L. koi [12] , S. parasitica [24] , T. theifer [25] , and S. atropurpurea [26] . Compound 6 has been encountered in T. theifer [25] , S. atropurpurea [26] and Tripodanthus acutifolius [27] , while 7 was previously isolated from Psittacanthus cuneifolius [28] and T. kaempferi [29] [30] . 5 g ) by silica gel VLC afforded five major fractions, GBPTE 1 -GBPTE 5. Purification of GBPTE 1 -GBPTE 3 (7.2 g) by silica gel CC gave 1 (465 mg, 2.9%) as colorless crystals, 2 (528.5 mg, 2.7%) as colorless crystals and 3 (121 mg, 0.3%) as yellow powder. Purification of GBPTE 4 (3.2 g) using silica gel CC afforded 4 (440.2 mg, 1%) as a pale brown powder. Fractionation of the MeOH-soluble extract (45 g) by silica gel VLC gave five major fractions, GBPTM 1 -GBPTM 5. Purification of GBPTM 3 -GBPTM 5 (2.7 g) by silica gel CC followed by Sephadex LH-20 CC afforded 5 (37 mg, 0.1%) as yellow solids and 6 (11.2 mg, 0.02%) as a reddish-brown powder while further purification of several sub-fractions using PTLC gave 7 (6.8 mg, 0.01%) as a yellow powder.
Experimental
Crystallographic Data of 1: Crystals were grown by dissolving the compounds in acetone and allowing for slow evaporation. Diffraction data for the compound was collected on a Bruker APEX 2 DUO CCD diffractometer using graphite-monochromated MoK α (λ = 0.71073 Å) radiation. Crystals were mounted on a MiTeGen MicroMount and collected at 100(2) K using an Oxford Cryosystems Cobra low-temperature device using strategies described earlier [31] [32] . Data were collected using omega and phi scans and corrected for Lorentz and polarization effects using the APEX software suite [33] . Using Olex2, the structure was solved with the XT structure solution program, using the intrinsic phasing solution method and refined against │F2│ with XL using least squares minimization. [34] [35] [36] . Non-hydrogen atoms were refined with anisotropically thermal parameters. Hydrogen atoms were generally placed in geometrically calculated positions and refined using a riding model. All images were rendered using Olex2 [34] . 
